LENSAR (NASDAQ:LNSR) Shares Up 0.9% – Here’s What Happened

Shares of LENSAR, Inc. (NASDAQ:LNSRGet Free Report) traded up 0.9% on Wednesday . The stock traded as high as $8.03 and last traded at $7.64. 50,678 shares changed hands during trading, an increase of 47% from the average session volume of 34,456 shares. The stock had previously closed at $7.57.

LENSAR Stock Down 2.1 %

The stock has a market capitalization of $87.69 million, a P/E ratio of -5.17 and a beta of 0.70. The company has a fifty day simple moving average of $6.49 and a two-hundred day simple moving average of $5.25.

Institutional Trading of LENSAR

A number of institutional investors have recently modified their holdings of LNSR. Sanctuary Advisors LLC acquired a new stake in shares of LENSAR in the second quarter valued at about $93,000. Geode Capital Management LLC increased its position in shares of LENSAR by 3.5% in the third quarter. Geode Capital Management LLC now owns 100,431 shares of the company’s stock valued at $460,000 after acquiring an additional 3,423 shares during the last quarter. DCF Advisers LLC increased its position in shares of LENSAR by 1.4% in the second quarter. DCF Advisers LLC now owns 241,484 shares of the company’s stock valued at $1,087,000 after acquiring an additional 3,250 shares during the last quarter. Finally, Brandes Investment Partners LP increased its position in shares of LENSAR by 12.8% in the second quarter. Brandes Investment Partners LP now owns 373,198 shares of the company’s stock valued at $1,644,000 after acquiring an additional 42,250 shares during the last quarter. 40.15% of the stock is currently owned by institutional investors.

About LENSAR

(Get Free Report)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Read More

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.